4 ms·
From the study abstract [1]: "In this largely vaccinated (84%) population, the posterior probability that ivermectin reduced symptom duration by more than 1 day
by simple10 4y ago
From the study abstract [1]: "In this largely vaccinated (84%) population, the posterior probability that ivermectin reduced symptom duration by more than 1 day was less than 0.1%."
"Importance: It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients with mild to moderate COVID-19."
My guess is this study will likely not convince certain doctors to stop prescribing ivermectin for unvaccinated patients with mild symptoms.
[1] https://jamanetwork.com/journals/jama/fullarticle/2801827 https://jamanetwork.com/journals/jama/fullarticle/2801827